¿What Should We Do About Significant Coronary Lesions in TAVR?

Aortic stenosis and coronary artery disease (CAD) share risk factors, which means significant lesions will coexist in approximately 50% of cases, especially in the elderly patients. 

When it comes to surgery, there is no question as to the approach. However, for TAVR patietns, the evidence remains inconclusive, seeing as we only have one randomized study and a few registries providing contradicting information. 

The NOTION 3 (randomized, open, superiority study) included 455 patients with severe aortic stenosis and CAD (significant lesion to ≥2.5 mm vessel with <0.80 FFR or ≥90% visual angiographic lesion). 227 of these patients received PCI and 228 were treated conservatively. 

Primary end point was a composite of all-cause death, myocardial infarction (MI) or emergency revascularization.

Both groups presented similar characteristics: mean age 81, one third were women, had 3% STS score and 60% ejection fraction. There were no significant differences in prevalence of PCI, MI, CABG, diabetes, stroke, atrial fibrillation, peripheral artery disease or COPD.

Read also: ESC 2024 | NOTION 3 Trial: Percutaneous Coronary Intervention in Patients with a Planned Transcatheter Aortic Valve Implantation.

Mean SYNTAX score was 9. PCI was done before TAVR in 74% of cases, during TAVR in 17%, and less frequently after procedure. 60% of valves were self-expanding while the rest were balloon expandable.  

At two-year follow-up, primary end point resulted in favor of PCI (26% vs. 36%, 0.71 HR; CI 95%, 0.51 to 0.99; P = 0.04). There were no significant differences in all-cause or cardiovascular mortality, MI or emergency revascularization, or in terms of major or minor bleeding, stent thrombosis or kidney failure. 

Conclusion

In patients with coronary artery disease undergoing TAVR, PCI was associated with a lower risk of all-cause mortality, myocardial infarction or emergency revascularization at 2-year follow-up. 

Original Title: PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation. NOTION 3 Trial.

Reference: J. Lønborg, R. Jabbari, et al. NEJM.org. DOI: 10.1056/NEJMoa2401513.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...

Plaque Ruptures in Non-Culprit Arteries: Follow-Up With Intravascular Imaging

Plaque rupture remains one of the most important pathophysiological mechanisms in acute coronary syndromes. However, not all ruptures manifest clinically as ischemia, myocardial infarction,...

OCT-Detected High-Risk Plaques Predict Recurrent Events After Myocardial Infarction

After a myocardial infarction (MI), non-culprit lesions are often deferred when they are not flow-limiting (negative FFR). However, these lesions continue to represent an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SPYRAL Program: 3-Year Outcomes in Patients Treated with Renal Denervation

Hypertension is the leading modifiable risk factor for cardiovascular disease and remains a major global health challenge, affecting more than one billion adults worldwide.  Despite...

Coronary Obstruction During TAVI: A New Volumetric Index to Consider

Coronary obstruction during TAVI is an uncommon but potentially catastrophic complication, particularly in valve-in-valve procedures, in anatomies with small sinuses of Valsalva, low coronary...

EARLY TAVR: Impact of Age on Outcomes of Early TAVR in Asymptomatic Patients

Asymptomatic severe aortic stenosis represents an increasingly common clinical challenge. Although current guidelines recommend intervention once symptoms develop or left ventricular dysfunction occurs, concerns...